Form 8-K - Current report:
SEC Accession No. 0001193125-21-161302
Filing Date
2021-05-14
Accepted
2021-05-14 07:55:32
Documents
13
Period of Report
2021-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d178995d8k.htm   iXBRL 8-K 25038
2 EX-99.1 d178995dex991.htm EX-99.1 27033
  Complete submission text file 0001193125-21-161302.txt   187968

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sldb-20210514.xsd EX-101.SCH 3069
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20210514_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20210514_pre.xml EX-101.PRE 11859
6 EXTRACTED XBRL INSTANCE DOCUMENT d178995d8k_htm.xml XML 3480
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 21921971
SIC: 2836 Biological Products, (No Diagnostic Substances)